Peter Gilbert, research professor of biostatistics and a biostatistician at Fred Hutch, comments on assessing safety and efficacy after an Emergency Use Authorization has been approved. Gilbert has helped design clinical trials for the leading U.S. vaccine candidates.
In the News
Six Biostatistics alumni are among the 50 Changemakers recognized by the School of Public Health as part of its 50th anniversary celebration. Congratulations to Garnet Anderson, Gary Churchill, Jeffrey Leek, Kung-Yee Liang, Xihong Lin, and Clarice R. Weinberg.
Professor of Biostatistics Tom Fleming is a member of WHO’s Solidarity Vaccines Trial group. He discusses the group's COVID-19 vaccine mega-trial, to start this month with a small study in Latin America.
Thomas R. Fleming, professor and former chair of biostatistics, received the 2020 Ward Cates Spirit Award from the HIV Prevention Trials Network (HPTN). The honor recognizes Fleming’s dedication, passion, and tireless pursuit of ensuring clinical trials are well designed, properly implemented, and correctly interpreted.
Fred Hutchinson Cancer Research Center biostatistician Dr. Ruth Etzioni was just named the inaugural recipient of the Rosalie & Harold Rea Brown Endowed Chair. The new endowed chair will help advance Etzioni’s population science research, which focuses on cancer screening and early detection, particularly in breast and prostate cancers. Etzioni is also a UW affiliate professor of biostatistics.
Elizabeth “Betz” Halloran, professor of biostatistics, is quoted in this piece about pharma companies using different playbooks to test their Covid-19 shots, noting the first team to claim victory may not have the best formula.
When the pandemic hit, Fred Hutch biostatistician and UW Affiliate Professor of Biostatistics Ruth Etzioni began to put her modeling chops to work on outmaneuvering COVID-19. “In a way, I feel like I’ve become a model whisperer,” she said.
Holly Janes, affiliate professor of biostatistics and a biostatistician at the Fred Hutchinson Cancer Research Center, is quoted in this article that answers frequently asked questions about large-scale vaccine efficacy studies.